This opportunity is no longer accepting applications.
grant RFA-AI-24-068

New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)

This grant opportunity aims to fund research for new treatments for genital herpes, focusing on suppressing the virus, reducing lesion formation, and minimizing transmission. It invites projects exploring various therapeutic approaches, including new antivirals, monoclonal antibodies, therapeutic vaccines, and gene editing technologies. The funding will be awarded in two phases, with continuat…

The purpose of this notice of funding opportunity (NOFO) is to stimulate the development of new treatments for genital herpes that suppress shedding and lesion formation and reduce transmission. This NOFO invites applications that propose research into a broad range of therapeutic approaches, in…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Dates

Opportunity Released: October 15, 2024
Open for Submission: October 15, 2024
Submission Deadline: January 31, 2025
Application Window Closes: January 31, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.